Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
If you think that marketing in the drug category is becoming less interesting and more monotonous, you’re right.
A ranking of the most-recalled prescription drug ads shows that prescription drug ads became less memorable for consumers between this year and last, as measured by Nielsen IAG, New York.
The drug ads consumers remembered best in 2007 were executions for Schering-Plough’s allergy drug Nasonex, Takeda’s sleeping pill Rozerem, Schering’s anti-cholesterol brand Vytorin, Pfizer’s anti-cholesterol brand Lipitor and its anti-smoking brand Chantix, and Sepracor’s insomnia med Lunesta.
But midway through 2008, all of those brands have run into controversy or economic difficulties, and some of them pulled much or their entire consumer advertising.
What
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in